Depression, Anxiety Clinical Trial
Official title:
A Pilot Randomised Dismantling Trial of the Efficacy of Self-As-Context During Acceptance and Commitment Therapy
NCT number | NCT03925259 |
Other study ID # | 144363 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 1, 2012 |
Est. completion date | June 1, 2014 |
Verified date | April 2019 |
Source | University of Sheffield |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The six processes within the psychological flexibility model of acceptance and commitment therapy (ACT) are seen as being equally theoretically and clinically important. The utility of self-as-context component however has never been isolated in a dismantling study. The present study therefore sought to conduct a pilot two-arm dismantling component study of ACT, quarantining the self-as-context component from one of the arms. Patients with a long-term health condition (LTC) and concurrent mental health condition were randomised into one of two study arms; (1) Full-ACT or (2) ACT minus self-as-context (ACT-SAC). Participants in each arm were compared with regards to their ability to engage in psychological flexibility and decentering. Clinical outcomes were compared at end of treatment and also at 6-weeks follow-up.
Status | Completed |
Enrollment | 16 |
Est. completion date | June 1, 2014 |
Est. primary completion date | January 1, 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility |
Inclusion Criteria: - Long term physical health condition and comorbid mental health problem - Age 16+ - Referred to a psychological therapies service Exclusion Criteria: - Diagnosis of 'medically unexplained symptoms' including somatoform disorders (e.g. pain disorder, conversion disorder, body dysmorphic disorder, hypochondriasis) and functional somatic syndromes (e.g. irritable bowel syndrome, chronic fatigue syndrome, fibromyalgia, non-cardiac chest pain, non-epileptic seizures) - Mental health diagnoses in addition to anxiety or depression (e.g. personality disorder, bipolar disorder or psychosis) - Currently accesses secondary care mental health services - Significant current suicidal risk - Current substance misuse - Previous contact with mental health services (defined as two or more prior episodes of service contact without significant change) - Inpatient admission for mental health difficulties within the last five years - History of self-injury - A stated reluctance to engage in psychotherapy. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Clinical Psychology Unit, Department of Psychology, Uni of Sheffield | Sheffield | Yorkshire |
Lead Sponsor | Collaborator |
---|---|
University of Sheffield |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in functioning via the Work and Social Adjustment Scale (WSAS; Mundt, Marks, Shear, & Greist, 2002). | The WSAS is a five-item measure of the impact of a health condition on five facets of daily functioning (work, home management, social leisure activities, private leisure activities, and close relationships). All items are scored on a 9-point rating scale from 0 to 8 with a score range of 0-40. Severity ratings are categorised as severe functional impairment >20, significant functional impairment 10-20, subclinical <10). Caseness is defined as scores of =10. The WSAS is sensitive to differences in disorder severity and is a sensitive to change (Purdie, Kellett, & Bickerstaffe, 2012). | WSAS (functioning) scores compared in the arms at final therapy session and at 6-week follow-up | |
Other | Changes to depression via The Patient Health Questionnaire (PHQ9; Spitzer, Kroenke & Williams; 1999) | The PHQ-9 is a nine-item measure, widely used within primary and secondary care settings to detect depression. All items are scored on a 4-point scale from 0 to 3 with a score range of 0-27. Severity ratings are categorised as severe >20, moderately severe 15-20, moderate 10-14, mild 5-9, remission <5). Caseness is defined as scores of =10 and the amount of pre to post treatment change needed to demonstrate statistically reliable change is defined as =6 (Gyani, Shafran, Layard, & Clark, 2011). Sensitivity and specificity have been identified at 92% and 80% respectively at the >10 cut off point (Gilbody, Richards, Brealey, & Hewitt, 2007). | PHQ-9 (depresion) scores compared in the arms at final therapy session and at 6-week follow-up | |
Other | Chnages to anxiety via The Generalised Anxiety Disorder Assessment (GAD7; Spitzer, Kroenke, Williams & Lowe; 2006). | The GAD-7 is a seven-item severity measure of generalised anxiety. All items are scored on a 4-point scale from 0 to 3 with a score range of 0-21. Severity ratings are categorised as severe >15, moderate 10-14, mild 5-9 & remission <5). Caseness is defined as scores of =8 and the amount of pre to post treatment change needed to demonstrate statistically reliable change is defined as =4 (Gyani et al., 2011). Applying a threshold score of 10 affords 89% sensitivity and 82% specificity (Swinson, 2006). The GAD-7 has also demonstrated sensitivity and specificity for the detection of other anxiety disorders (e.g. panic disorder, social anxiety disorder; Kroenke, Spitzer, Williams, Monahan & Lowe, 2007). | GAD-7 (anxiety) scores compared in the arms at final therapy session and at 6-week follow-up | |
Primary | Change in psychological flexibility abilities via the Acceptance and Action Questionnaire II (AAQ-II; Bond et al., 2011). | The AAQ-II is a 7-item measure of psychological inflexibility (score range 7-49) and is based on the widely researched Acceptance and Action Questionnaire (Hayes et al., 2004). The AAQ-II has sound psychometric properties (Bond et al., 2011). | AAQ-II (flexibility) scores compared in the arms at final therapy session and at 6-week follow-up | |
Secondary | Change in decentering abilities via the Experiences Questionnaire (EQ; Fresco, Moore, van Dulmen, Segal, Teasdale, Ma, & Williams, 2007). | The EQ is a 20-item measure of decentering and rumination. Only the EQ-decentering scale was used in the current study; this contains 11-items and so scores ranged from 11-55. The EQ has been shown to have good convergent, discriminant and internal consistency (Fresco, et al., 2007). The EQ-decentering scale has been cross-culturally validated and can detect changes in decentering abilities after mindfulness-based interventions (Soler et al., 2017). | EQ (decentering) scores compared in the arms at final therapy session and at 6-week follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04122482 -
An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises
|
N/A | |
Completed |
NCT04085861 -
Mental Health in Dancers; an Intervention Study
|
N/A | |
Recruiting |
NCT06060210 -
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion
|
Phase 4 | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Recruiting |
NCT06065787 -
NeuroGlove Anxiety and Depression Study
|
N/A | |
Active, not recruiting |
NCT04583891 -
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
|
N/A | |
Completed |
NCT05554042 -
Kintsugi Voice Device Study
|
||
Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
Not yet recruiting |
NCT06430853 -
Psychobiological Interventions in Pregnancy
|
N/A | |
Completed |
NCT02954250 -
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
|
Early Phase 1 | |
Recruiting |
NCT05647499 -
Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study
|
N/A | |
Completed |
NCT03980873 -
Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach
|
N/A | |
Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT05368155 -
Chronic Pelvic Pain and Education Skills Training for Women Veterans
|
N/A | |
Completed |
NCT05455905 -
Voice Biomarkers Predictive of Depression and Anxiety
|
||
Completed |
NCT03272516 -
Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients
|
N/A | |
Not yet recruiting |
NCT05493865 -
Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems
|
N/A | |
Not yet recruiting |
NCT06027047 -
Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
|
||
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Recruiting |
NCT04418115 -
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
|
N/A |